In vivo antitumor effect of cytotoxic T lymphocytes engineered to produce interferon-γ by adenovirus-mediated genetic transduction

Biochemical and Biophysical Research Communications

Volumn 218, Issue 1, 1996, Pages 164-170

  Abe, Junko ^a   Wakimoto, Hiroaki ^a,b   Tsunoda, Rikiya ^c   Okabe, Satoshi ^a   Yoshida, Yoko ^a   Aoyagi, Masaru ^b   Hirakawa, Kimiyoshi ^b   Hamada, Hirofumi ^a  

^a CANCER INSTITUTE   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON;

ADENOVIRUS; ADOPTIVE IMMUNOTHERAPY; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EXPRESSION VECTOR; GENE THERAPY; GENETIC TRANSDUCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR MODEL; VIRUS RECOMBINANT;

EID: 0030027137     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1996.0029     Document Type: Article

References (22)

1. Topalian, S. L., and Rosenberg, S. A. (1991) In Biologic Therapy of Cancer (De Vita, V. T. Jr., Hellman, S., and Rosenberg, S. A., Eds.) pp. 178-196 Lippincott, Philadelphia.
2. Rubin, J. T., and Lotze, M. T. (1993) pp. 379-410, in (Mitchell, M. S., Ed.) Biological Approaches to Cancer Treatment: Biomodulation, McGraw-Hill, New York.
3. Greenberg, P. D. (1991) Adv. Immunol. 49, 281-355.
4. Schreiber, H. (1993) in Fundamental Immunology, (Paul, W. E., Ed.), 3rd ed., pp. 1143-1178, Raven Press, New York.
5. Rosenberg, S. A., Aebersold, P., Cornetta, K., Kasid, A., Morgan, R. A., Moen, R., Karson, E. M., Lotze, M. T., Yang, J. C., Topalian, S. L., Merino, M. J., Culver, K., Miller, A. D., Blaese, R. M., and Anderson, W. F. (1990) N. Engl. J. Med. 323, 570-578.
6. Dranoff, G., and Mulligan, R. C. (1995) Adv. Immunol. 58, 417-454.
7. Nakamura, Y., Wakimoto, H., Abe, J., Kanegae, Y., Saito, I., Aoyagi, M., Hirakawa, K., and Hamada, H. (1994) Cancer Res. 54, 5757-5760.
8. Fidler, I. J. (1975) Cancer Res. 35, 218-224.
9. Abe, J., Wakimoto, H., Aoyagi, M., Hirakawa, K., and Hamada, H. (1995) Cancer Immunol. Immunother. 41, 82-86.
10. Saito, I., Oya, Y., Yamamoto, K., Yuasa, T., and Shimojo, H. (1985) J. Virol. 54, 711-719.
11. Attia, M. A. M., and Weiss, D. W. (1966) Cancer Res. 26, 1787-1800.
12. Niwa, H., Yamamura, K., and Miyazaki, J. (1991) Gene 108, 193-200.
13. Abe, J., Wakimoto, H., Yoshida, Y., Aoyagi, M., Hirakawa, K., and Hamada, H. (1995) J. Cancer Res. Clin. Oncol. in press.
14. Kurzrock, R., Talpaz, M., and Gutterman, J. U. (1991) in Biologic Therapy of Cancer pp. 247-274, (DeVita, V. T. Jr., Hellman, S., and Rosenberg, S. A., Lippincott, Philadelphia .
15. Borden, E. C., Witt, P. L., Paulnock, D. M., and Grossberg, S. (1993) in Biological Approaches to Cancer Treatment: Biomodulation (Mitchell, M. S., Ed.), pp. 440-476, McGraw-Hill, New York.
16. Nishihara, K., Miyatake, S., Sakata, T., Yamashita, J., Kikuchi, H., Kawade, Y., Zu, Y., Namba, Y., Hanaoka, M., and Watanabe, Y. (1988) Cancer Res. 48, 4730-4735.
17. Miyatake, S., Nishihara, K., Kikuchi, H., Yamashita, J., Namba, Y., Hanaoka, M., and Watanabe, Y. (1990) J. Natl. Cancer Inst. 82, 217-220.
18. Freedman, A. S., Freeman, G. J., Rhynhart, K., and Nadler, L. M. (1991) Cell. Immunol. 137, 429-437.
19. Terrell, T. G., and Green, J. D. (1993) Int. Rev. Exp. Pathol. 34B, 73-101.
20. Steinmann, G. G., Rosenkaimer, F., and Leitz, G. (1993) Int. Rev. Exp. Pathol. 34B, 193-207.
21. Harada, Y., and Yahara, I. (1993) Int. Rev. Exp. Pathol. 34A, 37-55.
22. Anderson, T. D., Hayes, T. J., Powers, G. D., Gately, M. K., Tudor, R., and Rushton, A. (1993) Int. Rev. Exp. Pathol. 34A, 57-77.